| abstract |
The present invention relates to (1) named glucocorticosteroid receptor agonists and (2) β 2 adrenergic agonists, dual β 2 adrenergic agonists / M 3 receptor antagonists, muscarinic antagonists, p38 kinase inhibitors, neutrophil elastase Pharmaceutical products comprising a combination of inhibitors, phosphodiesterase PDE4 inhibitors, IKK2 kinase inhibitors or nonsteroidal glucocorticoid receptor agonists, and the use of such products in the treatment of respiratory diseases. |